Calliditas Therapeutics Ab ADR (CALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CALT | ZTS | TAK | UTHR | NBIX |
| Company | Calliditas Therapeutics Ab ADR | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | United Therapeutic | Neurocrine Bioscienc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 23.41 | 166.57 | 16.49 | 218.79 | 96.41 |
| High | 23.65 | 166.80 | 16.52 | 219.22 | 97.26 |
| Low | 23.41 | 161.28 | 16.42 | 215.89 | 95.90 |
| Last | 23.50 | 162.66 | 16.47 | 217.23 | 97.10 |
| Change | +1.10 | -2.38 | +0.03 | -1.69 | +0.69 |
| % Change | +4.91% | -1.44% | +0.18% | -0.77% | +0.72% |
| Volume | 2,900 | 2,512,100 | 1,474,700 | 378,600 | 492,600 |
| 20-Day Average Volume | 21,135 | 2,019,895 | 2,464,905 | 671,725 | 689,385 |
| Previous Close | 22.40 | 165.04 | 16.44 | 218.92 | 96.41 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 21.72 | 165.40 | 16.09 | 225.41 | 96.79 |
| 20-Day Raw Stochastic | 78.35% | 25.98% | 92.14% | 15.02% | 45.76% |
| 20-Day Relative Strength | 58.30% | 47.75% | 61.53% | 35.98% | 41.82% |
| Weighted Alpha | +2.18 | -10.20 | +18.69 | +2.72 | -4.18 |
| Today's Opinion | 100% Buy | 24% Buy | 100% Buy | 72% Sell | 72% Sell |
| Previous Opinion | 100% Buy | 24% Buy | 100% Buy | 56% Sell | 88% Sell |
| Last Month's Opinion | 48% Buy | 56% Buy | 56% Buy | 8% Buy | 56% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.29% since 03/22/23 | +0.79% since 03/22/23 | +0.24% since 03/22/23 | +1.99% since 03/22/23 | +2.05% since 03/22/23 |
| Low | 21.09 on 03/27/23 | 159.39 on 03/23/23 | 16.14 on 03/23/23 | 212.15 on 03/23/23 | 94.86 on 03/23/23 |
| High | 24.26 on 03/23/23 | 166.80 on 03/29/23 | 16.53 on 03/27/23 | 221.96 on 03/27/23 | 97.69 on 03/28/23 |
| 1-Month | |||||
| %Chg | +26.96% since 02/28/23 | -2.60% since 02/28/23 | +7.30% since 02/28/23 | -11.71% since 02/28/23 | -5.82% since 02/28/23 |
| Low | 16.30 on 03/10/23 | 159.39 on 03/23/23 | 15.18 on 03/02/23 | 211.57 on 03/16/23 | 92.89 on 03/16/23 |
| High | 25.49 on 03/15/23 | 171.98 on 03/06/23 | 16.58 on 03/22/23 | 249.21 on 03/03/23 | 103.14 on 03/01/23 |
| 3-Month | |||||
| %Chg | +38.72% since 12/28/22 | +13.09% since 12/28/22 | +6.95% since 12/28/22 | -20.53% since 12/28/22 | -18.18% since 12/28/22 |
| Low | 16.30 on 03/10/23 | 141.52 on 01/06/23 | 15.18 on 03/02/23 | 211.57 on 03/16/23 | 92.89 on 03/16/23 |
| High | 25.49 on 03/15/23 | 176.66 on 02/14/23 | 16.58 on 03/22/23 | 279.14 on 01/06/23 | 125.01 on 01/06/23 |
| 6-Month | |||||
| %Chg | +66.43% since 09/28/22 | +6.83% since 09/28/22 | +26.01% since 09/28/22 | +2.91% since 09/28/22 | -5.57% since 09/28/22 |
| Low | 10.82 on 10/20/22 | 124.15 on 11/03/22 | 12.28 on 10/21/22 | 205.03 on 09/29/22 | 92.89 on 03/16/23 |
| High | 25.49 on 03/15/23 | 176.66 on 02/14/23 | 16.58 on 03/22/23 | 283.09 on 12/09/22 | 129.29 on 12/01/22 |
| Key Statistics | |||||
| Market Capitalization, $K | 667,206 | 76,477,384 | 52,025,880 | 10,136,432 | 9,312,049 |
| Shares Outstanding, K | 29,786 | 463,387 | 3,164,591 | 46,302 | 96,588 |
| Annual Sales | 79,570,000 | 8,080,000,000 | 31,764,150,000 | 1,936,300,000 | 1,488,700,000 |
| Annual Net Income | -40,860,000 | 2,114,000,000 | 2,047,530,000 | 727,300,000 | 154,500,000 |
| Last Quarter Sales | 40,040,000 | 2,040,000,000 | 7,785,510,000 | 491,500,000 | 412,000,000 |
| Last Quarter Net Income | -340,000 | 461,000,000 | 845,800,000 | 132,100,000 | 89,000,000 |
| 60-Month Beta | 1.48 | 0.76 | 0.64 | 0.62 | 0.50 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.01 on 02/23/23 | 1.15 on 02/14/23 | 0.46 on 02/02/23 | 2.67 on 02/22/23 | 0.88 on 02/06/23 |
| Latest Earnings Date | 05/17/23 | 05/04/23 | 05/10/23 | 05/03/23 | 05/03/23 |
| Most Recent Dividend | N/A | 0.375 on 01/19/23 | 0.270 on 09/29/22 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 04/20/23 | 09/29/22 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 33.96 | 8.58 | 14.51 | 63.43 |
